baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

NKT A/S/ DK0010287663 /

2024-04-18 12:00:00 AM	Chg. +8.00	Volume	Bid5:10:00 PM	Ask5:10:00 PM	Market Capitalization	Dividend Y.	P/E Ratio
598.00DKK	+1.36%	80,615 Turnover: 47.51 mill.	595.50Bid Size: -	596.50Ask Size: -	29.26 bill.DKK	-	-

GlobeNewswire 04-16 GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulat...

GlobeNewswire 04-08 GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society In...

GlobeNewswire 04-01 GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-28 GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference

GlobeNewswire 03-14 GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT...

GlobeNewswire 03-04 GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the U...

GlobeNewswire 03-04 Nektr Launches Airdrop and Raffle dApps Amid Recent Rebranding

Newsfile Corp 02-08 PlasCred beauftragt SCS Global Services mit der ISCC PLUS-Verifizierung zur Förderung seiner Verpfli...

GlobeNewswire 02-06 Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, In...

GlobeNewswire 02-02 GRI Bio Announces Pricing of $5.5 Million Public Offering

Newsfile Corp 01-29 PlasCred Circular Innovations Inc. und CN Rail unterzeichnen Absichtserklärung zur Nutzung der Logis...

GlobeNewswire 01-29 Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Techno...

GlobeNewswire 01-26 GRI Bio Announces Reverse Stock Split

GlobeNewswire 2023-12-05 GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 fo...

GlobeNewswire 2023-11-27 GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant N...

GlobeNewswire 2023-11-15 GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire 2023-10-31 GRI Bio Presents Data Supporting Innovative Pipeline of NKT Cell Modulators for the Treatment of Hig...

GlobeNewswire 2023-10-19 GRI Bio Presents Translational Data Demonstrating Connection Between NKT Cells and the Pathogenesis ...

GlobeNewswire 2023-10-17 GRI Bio Announces Partnership with the Respiratory Translational Research Collaboration to Advance L...

GlobeNewswire 2023-10-11 GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference

GlobeNewswire 2023-10-05 GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immu...

GlobeNewswire 2023-09-06 GRI Bio to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire 2023-08-23 GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy...

Newsfile Corp 2023-06-03 Royal Road und MSB Holdings schliessen joint venture-aktionärsvertrag für mineralienexploration ab

Newsfile Corp 2022-05-04 Royal Road durchteuft 181 Meter mit 1,1 Gramm pro Tonne Goldäquivalent auf seinem Kupfer- und Goldpr...

NKT A/S/ DK0010287663 /

If you wish to receive reply to your feedback, please provide your email address.